The number of people with glaucoma worldwide in 2010 and 2020
- PMID: 16488940
- PMCID: PMC1856963
- DOI: 10.1136/bjo.2005.081224
The number of people with glaucoma worldwide in 2010 and 2020
Abstract
Aim: To estimate the number of people with open angle (OAG) and angle closure glaucoma (ACG) in 2010 and 2020.
Methods: A review of published data with use of prevalence models. Data from population based studies of age specific prevalence of OAG and ACG that satisfied standard definitions were used to construct prevalence models for OAG and ACG by age, sex, and ethnicity, weighting data proportional to sample size of each study. Models were combined with UN world population projections for 2010 and 2020 to derive the estimated number with glaucoma.
Results: There will be 60.5 million people with OAG and ACG in 2010, increasing to 79.6 million by 2020, and of these, 74% will have OAG. Women will comprise 55% of OAG, 70% of ACG, and 59% of all glaucoma in 2010. Asians will represent 47% of those with glaucoma and 87% of those with ACG. Bilateral blindness will be present in 4.5 million people with OAG and 3.9 million people with ACG in 2010, rising to 5.9 and 5.3 million people in 2020, respectively.
Conclusions: Glaucoma is the second leading cause of blindness worldwide, disproportionately affecting women and Asians.
Conflict of interest statement
Competing interest: none declared
Comment in
-
Worldwide glaucoma through the looking glass.Br J Ophthalmol. 2006 Mar;90(3):253-4. doi: 10.1136/bjo.2005.083527. Br J Ophthalmol. 2006. PMID: 16488934 Free PMC article.
Similar articles
-
The Prevalence and the Incidence of Diagnosed Open-Angle Glaucoma and Diagnosed Angle-Closure Glaucoma: Changes From 2001 to 2010.J Glaucoma. 2016 May;25(5):e514-9. doi: 10.1097/IJG.0000000000000381. J Glaucoma. 2016. PMID: 26900828
-
Regional variations and trends in the prevalence of diagnosed glaucoma in the Medicare population.Ophthalmology. 2012 Jul;119(7):1342-51. doi: 10.1016/j.ophtha.2012.01.032. Epub 2012 Apr 4. Ophthalmology. 2012. PMID: 22480741
-
Prevalence and associated factors of glaucoma in the Russian Ural Eye and Medical Study.Sci Rep. 2020 Nov 20;10(1):20307. doi: 10.1038/s41598-020-77344-z. Sci Rep. 2020. PMID: 33219250 Free PMC article.
-
Angle-closure glaucoma: impact, etiology, diagnosis, and treatment.Curr Opin Ophthalmol. 2003 Apr;14(2):70-3. doi: 10.1097/00055735-200304000-00002. Curr Opin Ophthalmol. 2003. PMID: 12698044 Review.
-
The glaucomas.Minerva Med. 2001 Oct;92(5):365-79. Minerva Med. 2001. PMID: 11675580 Review.
Cited by
-
Responsiveness to ripasudil may be a potential outcome marker for selective laser trabeculoplasty in patients with primary open-angle glaucoma.Sci Rep. 2021 Mar 12;11(1):5812. doi: 10.1038/s41598-021-85271-w. Sci Rep. 2021. PMID: 33712673 Free PMC article.
-
Awareness and Knowledge of Glaucoma among Health Workers in Butajira General Hospital, South Ethiopia.Ethiop J Health Sci. 2022 Sep;32(5):923-928. doi: 10.4314/ejhs.v32i5.7. Ethiop J Health Sci. 2022. PMID: 36262701 Free PMC article.
-
Setting priorities for comparative effectiveness research on management of primary angle closure: a survey of Asia-Pacific clinicians.J Glaucoma. 2015 Jun-Jul;24(5):348-55. doi: 10.1097/IJG.0b013e31829e5616. J Glaucoma. 2015. PMID: 23835674 Free PMC article.
-
Effects of Netarsudil-Family Rho Kinase Inhibitors on Human Trabecular Meshwork Cell Contractility and Actin Remodeling Using a Bioengineered ECM Hydrogel.Front Ophthalmol (Lausanne). 2022 Jul 15;2:948397. doi: 10.3389/fopht.2022.948397. eCollection 2022. Front Ophthalmol (Lausanne). 2022. PMID: 38983571 Free PMC article.
-
Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations.Int Ophthalmol. 2017 Apr;37(2):423-428. doi: 10.1007/s10792-016-0280-x. Epub 2016 Jun 22. Int Ophthalmol. 2017. PMID: 27334605
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical